Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of cefazolin prophylaxis in elective cesarean section
IRCT20180525039834N1Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Jun 2018
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cefazolin in surgical site infection (SSI) (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoints: Endometritis, Wound infection and 4 more. Started Jun 2018; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20180525039834N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180525039834N1.